Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines-Reference-Cited by-同舟云学术

Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines

Published:2018-06 Issue:24 Volume:36 Page:3411-3417
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Vannice Kirsten S.,Wilder-Smith Annelies,Barrett Alan D.T.,Carrijo Kalinka,Cavaleri Marco,de Silva Aravinda,Durbin Anna P.,Endy Tim,Harris Eva,Innis Bruce L.,Katzelnick Leah C.,Smith Peter G.,Sun Wellington,Thomas Stephen J.,Hombach Joachim

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference44 articles.

1. Developing a dengue vaccine: progress and future challenges;Thomas;Ann N Y Acad Sci,2014

2. Antibody-dependent enhancement of severe dengue disease in humans;Katzelnick;Science,2017

3. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial;Capeding;Lancet Lond Engl,2014

4. Efficacy of a tetravalent dengue vaccine in children in Latin America;Villar;N Engl J Med,2015

5. Dengue vaccine: WHO position paper – July 2016;World Health Organization;Releve Epidemiol Hebd,2016

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dengue, Dengue hemorrhagic fever;International Encyclopedia of Public Health;2025

2. Efficacy, public health impact and optimal use of the Takeda dengue vaccine;2024-08-11

3. Mechanisms of antibody-dependent enhancement of infectious disease;Nature Reviews Immunology;2024-08-09

4. Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults;New England Journal of Medicine;2024-02

5. TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden;The Lancet Global Health;2024-02